302 related articles for article (PubMed ID: 16888151)
1. Complexing receptor pharmacology: modulation of family B G protein-coupled receptor function by RAMPs.
Sexton PM; Morfis M; Tilakaratne N; Hay DL; Udawela M; Christopoulos G; Christopoulos A
Ann N Y Acad Sci; 2006 Jul; 1070():90-104. PubMed ID: 16888151
[TBL] [Abstract][Full Text] [Related]
2. Identification of N-terminal receptor activity-modifying protein residues important for calcitonin gene-related peptide, adrenomedullin, and amylin receptor function.
Qi T; Christopoulos G; Bailey RJ; Christopoulos A; Sexton PM; Hay DL
Mol Pharmacol; 2008 Oct; 74(4):1059-71. PubMed ID: 18593822
[TBL] [Abstract][Full Text] [Related]
3. A critical role for the short intracellular C terminus in receptor activity-modifying protein function.
Udawela M; Christopoulos G; Morfis M; Christopoulos A; Ye S; Tilakaratne N; Sexton PM
Mol Pharmacol; 2006 Nov; 70(5):1750-60. PubMed ID: 16912219
[TBL] [Abstract][Full Text] [Related]
4. Functional interaction of G protein-coupled receptors of the adrenomedullin peptide family with accessory receptor-activity-modifying proteins (RAMP).
Born W; Muff R; Fischer JA
Microsc Res Tech; 2002 Apr; 57(1):14-22. PubMed ID: 11921352
[TBL] [Abstract][Full Text] [Related]
5. Identification and pharmacological characterization of domains involved in binding of CGRP receptor antagonists to the calcitonin-like receptor.
Salvatore CA; Mallee JJ; Bell IM; Zartman CB; Williams TM; Koblan KS; Kane SA
Biochemistry; 2006 Feb; 45(6):1881-7. PubMed ID: 16460034
[TBL] [Abstract][Full Text] [Related]
6. Receptor activity modifying proteins and their potential as drug targets.
Wootten DL; Simms J; Hay DL; Christopoulos A; Sexton PM
Prog Mol Biol Transl Sci; 2010; 91():53-79. PubMed ID: 20691959
[TBL] [Abstract][Full Text] [Related]
7. The effects of C-terminal truncation of receptor activity modifying proteins on the induction of amylin receptor phenotype from human CTb receptors.
Udawela M; Christopoulos G; Morfis M; Tilakaratne N; Christopoulos A; Sexton PM
Regul Pept; 2008 Jan; 145(1-3):65-71. PubMed ID: 17884192
[TBL] [Abstract][Full Text] [Related]
8. Receptor pharmacology.
Young A
Adv Pharmacol; 2005; 52():47-65. PubMed ID: 16492540
[TBL] [Abstract][Full Text] [Related]
9. RAMPs: The past, present and future.
Parameswaran N; Spielman WS
Trends Biochem Sci; 2006 Nov; 31(11):631-8. PubMed ID: 17010614
[TBL] [Abstract][Full Text] [Related]
10. Deletions of genes encoding calcitonin/alpha-CGRP, amylin and calcitonin receptor have given new and unexpected insights into the function of calcitonin receptors and calcitonin receptor-like receptors in bone.
Lerner UH
J Musculoskelet Neuronal Interact; 2006; 6(1):87-95. PubMed ID: 16675892
[TBL] [Abstract][Full Text] [Related]
11. The role of peptides and receptors of the calcitonin family in the regulation of bone metabolism.
Naot D; Cornish J
Bone; 2008 Nov; 43(5):813-8. PubMed ID: 18687416
[TBL] [Abstract][Full Text] [Related]
12. Distinct receptor activity-modifying protein domains differentially modulate interaction with calcitonin receptors.
Udawela M; Christopoulos G; Tilakaratne N; Christopoulos A; Albiston A; Sexton PM
Mol Pharmacol; 2006 Jun; 69(6):1984-9. PubMed ID: 16531504
[TBL] [Abstract][Full Text] [Related]
13. Functional characterization of two human receptor activity-modifying protein 3 variants.
Bailey RJ; Bradley JW; Poyner DR; Rathbone DL; Hay DL
Peptides; 2010 Apr; 31(4):579-84. PubMed ID: 20034525
[TBL] [Abstract][Full Text] [Related]
14. Modulating receptor function through RAMPs: can they represent drug targets in themselves?
Sexton PM; Poyner DR; Simms J; Christopoulos A; Hay DL
Drug Discov Today; 2009 Apr; 14(7-8):413-9. PubMed ID: 19150656
[TBL] [Abstract][Full Text] [Related]
15. Ligand binding and activation of the CGRP receptor.
Conner AC; Simms J; Barwell J; Wheatley M; Poyner DR
Biochem Soc Trans; 2007 Aug; 35(Pt 4):729-32. PubMed ID: 17635135
[TBL] [Abstract][Full Text] [Related]
16. Flow cytometric analysis of the calcitonin receptor-like receptor domains responsible for cell-surface translocation of receptor activity-modifying proteins.
Kuwasako K; Kitamura K; Nagata S; Kato J
Biochem Biophys Res Commun; 2009 Jun; 384(2):249-54. PubMed ID: 19394311
[TBL] [Abstract][Full Text] [Related]
17. Molecular mechanisms of ligand binding, signaling, and regulation within the superfamily of G-protein-coupled receptors: molecular modeling and mutagenesis approaches to receptor structure and function.
Kristiansen K
Pharmacol Ther; 2004 Jul; 103(1):21-80. PubMed ID: 15251227
[TBL] [Abstract][Full Text] [Related]
18. Receptor autoradiography as mean to explore the possible functional relevance of neuropeptides: focus on new agonists and antagonists to study natriuretic peptides, neuropeptide Y and calcitonin gene-related peptides.
Dumont Y; Chabot JG; Quirion R
Peptides; 2004 Mar; 25(3):365-91. PubMed ID: 15134861
[TBL] [Abstract][Full Text] [Related]
19. Adrenomedullin and CGRP interact with endogenous calcitonin-receptor-like receptor in endothelial cells and induce its desensitisation by different mechanisms.
Nikitenko LL; Blucher N; Fox SB; Bicknell R; Smith DM; Rees MC
J Cell Sci; 2006 Mar; 119(Pt 5):910-22. PubMed ID: 16495482
[TBL] [Abstract][Full Text] [Related]
20. The receptor activity modifying protein family of G protein coupled receptor accessory proteins.
Udawela M; Hay DL; Sexton PM
Semin Cell Dev Biol; 2004 Jun; 15(3):299-308. PubMed ID: 15125893
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]